PofoliaShared via Pofolia

JAMA Internal Medicine· 2026Q1

Universal Opt-Out Hepatitis C Virus Testing and Treatment on Entry in California State Prisons

Ziping Ye, Kimberley D. Lucas, Nathan W. Furukawa, Amanda Honeycutt et al.

Short summary

Universal opt-out hepatitis C virus (HCV) testing upon entry to California state prisons identified a high prevalence of HCV infection, with a significant proportion of individuals initiating treatment.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Universal opt-out HCV testing was implemented for all individuals entering California state prisons.
  • The program aimed to identify and treat HCV infections within the incarcerated population.
  • The study investigated testing and treatment outcomes associated with this universal screening approach.

AI-generated from the title and abstract; the full text is not read.

Abstract

This cross-sectional study investigates hepatitis C virus (HCV) testing and treatment outcomes among individuals entering California state prisons with universal opt-out HCV testing on entry.

The authors' abstract, as published at the source. JAMA Internal Medicine, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Hepatology

HepatologyMedicine